10 questions about acute stroke imaging: Ct versus mri-"the controversy"

Neurologist

Volumn 15, Issue 2, 2009, Pages 105-107

  Hsia, Amie W ^a,b,c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WHC Stroke Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; GADOLINIUM;

CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STROKE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63749100387     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31816bae90     Document Type: Note

References (20)

1. Selwa L, Chimowitz M. Atherosclerotic intracranial large artery disease. The Neurologist. 1995; 1:53-64.
2. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711.
3. Kidwell CS CJ, Saver JL, Hill M, Demchuk A, et al. Prospective comparison of CT vs. DWI for detection of acute cerebral ischemia: results of a multicenter study. Presented at: International Stroke Conference; 2005; New Orleans, LA.
4. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab. 1998;18:583-609.
5. Lev MH, Nichols SJ. Computed tomographic angiography and computed tomographic perfusion imaging of hyperacute stroke. Top Magn Reson Imaging. 2000;11:273-287.
6. Kang D-W, Chalela JA, Dunn W, et al.; Investigators NI-SSC. MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke. 2005;36:1939-1943.
7. Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004;292:1823-1830.
8. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update-a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:2001-2023.
9. Hjort N, Butcher K, Davis SM, et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke. 2005;36:388-397.
10. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000; 47:462-469.
11. Chalela JA, Kang DW, Luby M, et al. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol. 2004;55:105-112.
12. Sobesky J, Zaro Weber O, Lehnhardt FG, et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke. 2005;36: 980-985.
13. Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006;37:979-985.
14. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.
15. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
16. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37: 1227-1231.
17. Barber PA, Parsons MW, Desmond PM, et al. The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials. J Neuroimaging. 2004;14:123-132.
18. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol. 1997;42:164-170.
19. Tong DC, Yenari MA, Albers GW, et al. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 1998;50:864-870.
20. Information for Healthcare Professionals. Gadolinium-based contrast agents for magnetic resonance imaging. Available at http://www.fda.gov/cder/ drug/InfoSheets/HCP/gcca-200705.htm.